Article

ASCRS 2023:Eye Care Leaders partners with DavLong to Improve customer support for key software suites

Author(s):

According to the companies, the expanded partnership will enhance the MedFlow and MDOffice software suites.

Eye Care Leaders announced an expanded partnership with DavLong Business Solutions, a long tenured channel-partner of ECL. Both companies are on hand at ASCRS in San Diego. (Image courtesy of Adobe Stock)

Eye Care Leaders announced an expanded partnership with DavLong Business Solutions, a long tenured channel-partner of ECL. Both companies are on hand at ASCRS in San Diego. (Image courtesy of Adobe Stock)

Eye Care Leaders (ECL) today announced an expanded partnership with DavLong Business Solutions (DavLong), a long tenured channel-partner of ECL.

According to the companies, effective June 1, DavLong will be the exclusive licensee of MedFlow and MDOffice and will assume product development, service, and support for their customers. This partnership reinforces the offerings of each software suite and will strengthen the future of the MedFlow and MDOffice platforms.

The companies also noted ECL will also continue to support and invest in the iMedicWare, MyVision Express, and Management Plus EMR and Practice Management suites, ensuring that practices using any of these products can continue to provide the best patient care.

DavLong was founded more than 40 years ago to provide technology solutions for a wide range of businesses and since then has narrowed their focus to the medical industry. As one of the first ECL reseller partners and technical service providers for MedFlow, DavLong has the necessary experience and clinical expertise that prioritizes the service and support needs of practices.

With this long-standing partnership and shared objectives, both companies expect "business as usual" to continue for MedFlow and MDOffice customers with no disruption to current clinical and administrative workflows. Further details will be shared prior to June 1 , and both ECL and DavLong will be available at the 2023 ASCRS Annual Meeting to answer any questions.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.